AJMC - Managed Care News, Research, and Expert Insights
The American Journal of Managed Care provides insights into the latest news and research in managed care across multimedia platforms.
AJMC - Managed Care News, Research, and Expert Insights
About the Journal. An independent, peer-reviewed, monthly publication dedicated to disseminating clinical information to managed care physicians, clinical decision makers, and other health care ...
Issues Of The American Journal of Managed Care - AJMC
The American Journal of Managed Care® is the leading peer-reviewed journal dedicated to issues in managed care. Founded in 1995, it is an independent, peer-reviewed, monthly publication dedicated ...
The American Journal of Managed Care - AJMC
About AJMC. Purpose: Founded in 1995, The American Journal of Managed Care ® (AJMC ®) provides a forum for peer-reviewed literature on healthcare outcomes research.It is an independent, peer ...
Clinical - AJMC
2025年1月13日 · The AJMC® clinical page includes all the published content across AJMC.com, The American Journal of Managed Care® and Evidence-Based Oncology™ on a variety of specialties, including ...
About Us - AJMC
The American Journal of Managed Care® (AJMC®) is a leader in managed care research, offering actionable insights and peer perspectives through our leading peer-reviewed journals, AJMC®, The ...
American Journal of Managed Care News & Expert Insights - AJMC
The American Journal of Managed Care News section is a comprehensive resource for clinical news and expert insights. Read more at AJMC.
Latest Conference Articles - AJMC
2025年1月15日 · The expert knowledge presented at this year’s International Myeloma Society (IMS) annual meeting focused on minimal residual disease testing and status, defining and treating high-risk disease ...
Year in Review: Non-Small Cell Lung Cancer - ajmc.com
23 小时之前 · This year in review of 2024 milestones in non–small cell lung cancer (NSCLC) features coverage of the LAURA trial presented in June at the American Society of Clinical Oncology meeting in ...
Abelacimab, a “Game Changer” for High-Risk Patients With AFib: …
2 天之前 · Key Takeaways. Abelacimab shows a 62% reduction in major or clinically relevant non-major bleeding compared to rivaroxaban in AFib patients. The study highlights an 89% reduction in ...